Research·October 24, 2026 at 1:00 PM EDT·1 source
STAT+: The ESMO presentation everyone’s been waiting for
MRNA -1.2%MRK
MRNA · last 30 trading days-1.2% since the news
News
What happened
- Moderna and Merck delivered a high-profile presentation at the European Society for Medical Oncology meeting in Madrid.
- The presentation was among the news highlighted from Day 2 of the oncology meeting.
Why it matters
The presentation may be relevant to healthcare professionals tracking oncology developments and Moderna and Merck’s clinical or commercial activity.
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 23The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- EarlierYesterdayModerna Investors Should Brace for More Whiplash
- EarlierYesterdayCancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- EarlierYesterdayWells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
- First reported by STATYesterdaySTAT+: The ESMO presentation everyone’s been waiting for
Who is involved
STAT+: The ESMO presentation everyone’s been waiting forModernaMRNAMerckMRK
Company
Sources (1)
Related
- Yesterday · Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
- Oct 21 · Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Yesterday · Cancer vaccine data from #ESMO26; Treasury proposal could curb China investment; and more
- Yesterday · Moderna Investors Should Brace for More Whiplash
- Oct 23 · The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oct 23 · Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.